Watch Ticker

UroGen Pharma Ltd. Ordinary Shares

Go to UroGen Pharma Ltd. Ordinary Shares Website

$20.50

0.62 (3.12%)

Live

Previous Close

$20.72

Day Range

$19.555 - $21.015

Previous Day Range

$19.0989 - $20.1299

Market Cap

$918.5 million USD

Day Vol.

1.8 million

Previous Day Vol.

1.1 million

Currency

USD

Primary Exchange

Nasdaq

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Bragar Eagel & Squire, P.C. - UROGEN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds UroGen Pharma (URGN) Investors of the July 28th Deadline and Urges Investors to Inquire About Their Rights in Class Action Lawsuit

A class action lawsuit has been filed against UroGen Pharma regarding its UGN-102 drug application, alleging misleading statements about clinical study design and FDA approval risks. The stock price dropped significantly after FDA advisory committee voted against drug approval.

Related tickers: URGN.

Read Full Article

Bragar Eagel & Squire, P.C. - UROGEN ALERT: Bragar Eagel & Squire, P.C. Urges Investors in UroGen Pharma (URGN) to Inquire About Their Rights in Class Action Lawsuit

A class action lawsuit has been filed against UroGen Pharma regarding its UGN-102 drug application, alleging misleading statements about clinical study design and FDA approval risks.

Related tickers: URGN.

Read Full Article

Trending Tickers

Please sign in to view